Literature DB >> 23553857

Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome.

Carmilla M M Licht1, Eco J C de Geus, Brenda W J H Penninx.   

Abstract

CONTEXT: Stress is suggested to lead to metabolic dysregulations as clustered in the metabolic syndrome. Although dysregulation of the autonomic nervous system is found to associate with the metabolic syndrome and its dysregulations, no longitudinal study has been performed to date to examine the predictive value of this stress system in the development of the metabolic syndrome.
OBJECTIVE: We examined whether autonomic nervous system functioning predicts 2-year development of metabolic abnormalities that constitute the metabolic syndrome.
DESIGN: Data of the baseline and 2-year follow-up assessment of a prospective cohort: the Netherlands Study of Depression and Anxiety was used.
SETTING: Participants were recruited in the general community, primary care, and specialized mental health care organizations. PARTICIPANTS: A group of 1933 participants aged 18-65 years. MAIN OUTCOME MEASURES: The autonomic nervous system measures included heart rate (HR), respiratory sinus arrhythmia (RSA; high RSA reflecting high parasympathetic activity), pre-ejection period (PEP; high PEP reflecting low sympathetic activity), cardiac autonomic balance (CAB), and cardiac autonomic regulation (CAR). Metabolic syndrome was based on the updated Adult Treatment Panel III criteria and included high waist circumference, serum triglycerides, blood pressure, serum glucose, and low high-density lipoprotein (HDL) cholesterol.
RESULTS: Baseline short PEP, low CAB, high HR, and CAR were predictors of an increase in the number of components of the metabolic syndrome during follow-up. High HR and low CAB were predictors of a 2-year decrease in HDL cholesterol, and 2-year increase in diastolic and systolic blood pressure. Short PEP and high CAR also predicted a 2-year increase in systolic blood pressure, and short PEP additionally predicted 2-year increase in diastolic blood pressure. Finally, a low baseline RSA was predictive for subsequent decreases in HDL cholesterol.
CONCLUSION: Increased sympathetic activity predicts an increase in metabolic abnormalities over time. These findings suggest that a dysregulation of the autonomic nervous system is an important predictor of cardiovascular diseases and diabetes through dysregulating lipid metabolism and blood pressure over time.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553857     DOI: 10.1210/jc.2012-3104

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Exercise Frequency Determines Heart Rate Variability Gains in Older People: A Meta-Analysis and Meta-Regression.

Authors:  Jérémy Raffin; Jean-Claude Barthélémy; Caroline Dupré; Vincent Pichot; Mathieu Berger; Léonard Féasson; Thierry Busso; Antoine Da Costa; Alain Colvez; Claude Montuy-Coquard; Rémi Bouvier; Bienvenu Bongue; Frédéric Roche; David Hupin
Journal:  Sports Med       Date:  2019-05       Impact factor: 11.136

2.  Inner ear symptoms: can we use them to approach cardiovascular diseases?

Authors:  Antonio Pirodda; Arrigo Francesco Giuseppe Cicero; Cristina Brandolini; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2014-09-24       Impact factor: 3.397

3.  Associations of immunometabolic risk factors with symptoms of depression and anxiety: The role of cardiac vagal activity.

Authors:  Mandy X Hu; Brenda W J H Penninx; Eco J C de Geus; Femke Lamers; Dora C-H Kuan; Aidan G C Wright; Anna L Marsland; Matthew F Muldoon; Stephen B Manuck; Peter J Gianaros
Journal:  Brain Behav Immun       Date:  2018-06-18       Impact factor: 7.217

Review 4.  Translational Neuroscience in Autism: From Neuropathology to Transcranial Magnetic Stimulation Therapies.

Authors:  Manuel F Casanova; Estate M Sokhadze; Emily L Casanova; Ioan Opris; Caio Abujadi; Marco Antonio Marcolin; Xiaoli Li
Journal:  Psychiatr Clin North Am       Date:  2020-04-08

5.  Acute psychological stress, autonomic function, and arterial stiffness among women.

Authors:  Jeongok G Logan; Bethany A Teachman; Xiaoyue Liu; Charles R Farber; Zhenqi Liu; Brian H Annex
Journal:  Int J Psychophysiol       Date:  2020-06-30       Impact factor: 2.997

6.  Hyperinsulinemia in newly diagnosed patients with multiple sclerosis.

Authors:  Adela Penesova; Miroslav Vlcek; Richard Imrich; Lucia Vernerova; Andrea Marko; Milada Meskova; Lucia Grunnerova; Peter Turcani; Daniela Jezova; Branislav Kollar
Journal:  Metab Brain Dis       Date:  2015-03-27       Impact factor: 3.584

Review 7.  Positive psychological characteristics in diabetes: a review.

Authors:  Christopher M Celano; Eleanor E Beale; Shannon V Moore; Deborah J Wexler; Jeff C Huffman
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

8.  Juvenile onset depression alters cardiac autonomic balance in response to psychological and physical challenges.

Authors:  Lauren M Bylsma; Ilya Yaroslavsky; Jonathan Rottenberg; J Richard Jennings; Charles J George; Enikő Kiss; Krisztina Kapornai; Kitti Halas; Roberta Dochnal; Eszter Lefkovics; István Benák; Ildikó Baji; Ágnes Vetró; Maria Kovacs
Journal:  Biol Psychol       Date:  2015-07-29       Impact factor: 3.251

9.  Accumulation of Pericardial Fat Is Associated With Alterations in Heart Rate Variability Patterns in Hypercholesterolemic Pigs.

Authors:  Domingo E Uceda; Xiang-Yang Zhu; John R Woollard; Christopher M Ferguson; Ioannis Patras; Daniel F Carlson; Samuel J Asirvatham; Amir Lerman; Lilach O Lerman
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-03-19

Review 10.  Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.

Authors:  Biljana Musicki; Anthony J Bella; Trinity J Bivalacqua; Kelvin P Davies; Michael E DiSanto; Nestor F Gonzalez-Cadavid; Johanna L Hannan; Noel N Kim; Carol A Podlasek; Christopher J Wingard; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-12-08       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.